BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25402754)

  • 1. Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapy.
    Yang G; Kong Q; Wang G; Jin H; Zhou L; Yu D; Niu C; Han W; Li W; Cui J
    Cancer Biother Radiopharm; 2014 Dec; 29(10):428-34. PubMed ID: 25402754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
    J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cell Functional Activity After 4-1BB Costimulation.
    Navabi Ss; Doroudchi M; Tashnizi AH; Habibagahi M
    Inflammation; 2015; 38(3):1181-90. PubMed ID: 25520217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
    Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    Clin Immunol; 2008 Oct; 129(1):145-54. PubMed ID: 18707922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus.
    Lim DS; Yawata N; Selva KJ; Li N; Tsai CY; Yeong LH; Liong KH; Ooi EE; Chong MK; Ng ML; Leo YS; Yawata M; Wong SB
    J Immunol; 2014 Nov; 193(10):5065-75. PubMed ID: 25320280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.
    Bergmann C; Wild CA; Narwan M; Lotfi R; Lang S; Brandau S
    Eur J Immunol; 2011 Dec; 41(12):3564-73. PubMed ID: 21905023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line.
    Cheng M; Ma J; Chen Y; Zhang J; Zhao W; Zhang J; Wei H; Ling B; Sun R; Tian Z
    Cell Transplant; 2011; 20(11-12):1731-46. PubMed ID: 21669033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine secretion is distinct from secretion of cytotoxic granules in NK cells.
    Reefman E; Kay JG; Wood SM; Offenhäuser C; Brown DL; Roy S; Stanley AC; Low PC; Manderson AP; Stow JL
    J Immunol; 2010 May; 184(9):4852-62. PubMed ID: 20368273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
    Pintaric M; Gerner W; Saalmüller A
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy.
    Granzin M; Soltenborn S; Müller S; Kollet J; Berg M; Cerwenka A; Childs RW; Huppert V
    Cytotherapy; 2015 May; 17(5):621-32. PubMed ID: 25881519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function.
    Jiang W; Zhang C; Tian Z; Zhang J
    Gene Ther; 2013 Nov; 20(11):1062-9. PubMed ID: 23759701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
    Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W
    Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: implication in NK cell-based adoptive cellular immunotherapy.
    Zhang J; Sun R; Wei H; Zhang J; Tian Z
    Oncol Rep; 2004 May; 11(5):1097-106. PubMed ID: 15069553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
    Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
    J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and functional characterization of NK cells in human immune response against the dimorphic fungus Paracoccidioides brasiliensis.
    Longhi LN; da Silva RM; Fornazim MC; Spago MC; de Oliveira RT; Nowill AE; Blotta MH; Mamoni RL
    J Immunol; 2012 Jul; 189(2):935-45. PubMed ID: 22723518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
    Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.